Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Kagabu M, Shoji T, Murakami K, Omi H, Honda T, Miura F, Yokoyama Y, Tokunaga H, Takano T, Ohta T, Shimizu D, Sato N, Soeda S, Watanabe T, Yamada H, Mizunuma H, Yaegashi N, Nagase S, Tase T, Sugiyama T. Kagabu M, et al. Among authors: honda t. Int J Clin Oncol. 2016 Aug;21(4):735-740. doi: 10.1007/s10147-016-0946-4. Epub 2016 Jan 19. Int J Clin Oncol. 2016. PMID: 26782958
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T, Takatori E, Furutake Y, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Kumagai S, Yoshizaki A, Sato A, Sugiyama T. Shoji T, et al. Among authors: honda t. Int J Clin Oncol. 2016 Dec;21(6):1120-1127. doi: 10.1007/s10147-016-1008-7. Epub 2016 Jun 24. Int J Clin Oncol. 2016. PMID: 27342833 Free PMC article. Clinical Trial.
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass.
Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T. Takatori E, et al. Among authors: honda t. Onco Targets Ther. 2016 Sep 13;9:5651-5657. doi: 10.2147/OTT.S101146. eCollection 2016. Onco Targets Ther. 2016. PMID: 27695343 Free PMC article.
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Shoji T, Takatori E, Omi H, Kagabu M, Honda T, Futagami M, Yokoyama Y, Kaiho M, Tokunaga H, Otsuki T, Takano T, Yaegashi N, Kojimahara T, Ohta T, Nagase S, Soeda S, Watanebe T, Nishiyama H, Sugiyama T. Shoji T, et al. Among authors: honda t. Cancer Chemother Pharmacol. 2017 Aug;80(2):355-361. doi: 10.1007/s00280-017-3363-0. Epub 2017 Jun 27. Cancer Chemother Pharmacol. 2017. PMID: 28656383 Free PMC article. Clinical Trial.
3,454 results